These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 17296442

  • 1. Intravesical suplatast tosilate (IPD-1151T) inhibits experimental bladder inflammation.
    Boucher W, Kempuraj D, Cao J, Papaliodis D, Theoharides TC.
    J Urol; 2007 Mar; 177(3):1186-90. PubMed ID: 17296442
    [Abstract] [Full Text] [Related]

  • 2. [Inhibitory effect of IPD-1151T (suplatast tosilate) on mast cell induction from normal mouse spleen cells].
    Kouno S, Adachi M, Asano K, Okamoto K, Takahashi T.
    Arerugi; 1992 Oct; 41(10):1488-91. PubMed ID: 1336362
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of suplatast tosilate (IPD-1151T) in a rat cystitis model induced by intravesical hydrochloric acid.
    Kirimoto T, Nakano K, Irimura K, Hayashi Y, Matsuura N, Kiniwa M, Oka T, Yoshimura N.
    BJU Int; 2007 Oct; 100(4):935-9. PubMed ID: 17714534
    [Abstract] [Full Text] [Related]

  • 4. Acute stress and intravesical corticotropin-releasing hormone induces mast cell dependent vascular endothelial growth factor release from mouse bladder explants.
    Cao J, Boucher W, Kempuraj D, Donelan JM, Theoharides TC.
    J Urol; 2006 Sep; 176(3):1208-13. PubMed ID: 16890727
    [Abstract] [Full Text] [Related]

  • 5. Intravesical nanocrystalline silver decreases experimental bladder inflammation.
    Boucher W, Stern JM, Kotsinyan V, Kempuraj D, Papaliodis D, Cohen MS, Theoharides TC.
    J Urol; 2008 Apr; 179(4):1598-602. PubMed ID: 18295255
    [Abstract] [Full Text] [Related]

  • 6. Improvement of interstitial cystitis symptoms and problems that developed during treatment with oral IPD-1151T.
    Ueda T, Tamaki M, Ogawa O, Yamauchi T, Yoshimura N.
    J Urol; 2000 Dec; 164(6):1917-20. PubMed ID: 11061880
    [Abstract] [Full Text] [Related]

  • 7. Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.
    Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC.
    J Urol; 2002 Jan; 167(1):380-4. PubMed ID: 11743360
    [Abstract] [Full Text] [Related]

  • 8. The inhibitory effect of anti-allergic agent suplatast tosilate (IPD-1151T) on methacholine- and allergen-induced bronchoconstriction in sensitized mice. asakazu@med.showa-u.dc.jp.
    Asano K, Mizutani T, Shimane T, Hisano M, Hisamitsu T, Suzaki H.
    Mediators Inflamm; 2000 Jan; 9(2):77-84. PubMed ID: 10958380
    [Abstract] [Full Text] [Related]

  • 9. Suppressive effects of IPD-1151T (suplatast-tosilate) on induction of mast cells from normal mouse splenocytes.
    Konno S, Adachi M, Asano K, Gonogami Y, Ikeda K, Okamoto K, Takahashi T.
    Eur J Pharmacol; 1994 Jun 23; 259(1):15-20. PubMed ID: 7957588
    [Abstract] [Full Text] [Related]

  • 10. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G, Decot V, Loiseau S, Loyens M, Chihara J, Ono N, Capron M.
    Clin Exp Allergy; 2004 Sep 23; 34(9):1379-87. PubMed ID: 15347370
    [Abstract] [Full Text] [Related]

  • 11. [Effect of suplatast tosilate (IPD-1151T) on types I-IV allergic reactions].
    Matsuura N, Mori H, Nagai H, Koda A.
    Nihon Yakurigaku Zasshi; 1992 Dec 23; 100(6):495-501. PubMed ID: 1282894
    [Abstract] [Full Text] [Related]

  • 12. Effect of IPD-1151T (Suplatast Tosilate) on airway hyperresponsiveness in mice.
    Konno S, Asano K, Gonokami Y, Kurokawa M, Kawazu K, Adachi M.
    Arerugi; 1995 May 23; 44(5):556-61. PubMed ID: 7619009
    [Abstract] [Full Text] [Related]

  • 13. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (1). Regulation of murine IgE response.
    Yanagihara Y, Kiniwa M, Ikizawa K, Yamaya H, Shida T, Matsuura N, Koda A.
    Jpn J Pharmacol; 1993 Jan 23; 61(1):23-30. PubMed ID: 8382322
    [Abstract] [Full Text] [Related]

  • 14. Pentosanpolysulfate inhibits mast cell histamine secretion and intracellular calcium ion levels: an alternative explanation of its beneficial effect in interstitial cystitis.
    Chiang G, Patra P, Letourneau R, Jeudy S, Boucher W, Green M, Sant GR, Theoharides TC.
    J Urol; 2000 Dec 23; 164(6):2119-25. PubMed ID: 11061939
    [Abstract] [Full Text] [Related]

  • 15. Suppression of IgE production by IPD-1151T (suplatast tosilate), a new dimethylsulfonium agent: (2). Regulation of human IgE response.
    Yanagihara Y, Kiniwa M, Ikizawa K, Shida T, Matsuura N, Koda A.
    Jpn J Pharmacol; 1993 Jan 23; 61(1):31-9. PubMed ID: 8382323
    [Abstract] [Full Text] [Related]

  • 16. [A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T)].
    Watanabe M, Yamaguchi K, Yamanishi T, Kamai T, Yoshida K.
    Hinyokika Kiyo; 2009 Nov 23; 55(11):715-9. PubMed ID: 19946192
    [Abstract] [Full Text] [Related]

  • 17. IPD-1151T: a prototype drug for IgE antibody synthesis modulation.
    Koda A, Yanagihara Y, Matsuura N.
    Agents Actions Suppl; 1991 Nov 23; 34():369-78. PubMed ID: 1665310
    [Abstract] [Full Text] [Related]

  • 18. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
    Murakami T, Yamanaka K, Tokime K, Kurokawa I, Tsutsui H, Nakanishi K, Mizutani H.
    Br J Dermatol; 2006 Jul 23; 155(1):27-32. PubMed ID: 16792748
    [Abstract] [Full Text] [Related]

  • 19. IPD-1151T (suplatast tosilate) inhibits interleukin (IL)-13 release but not IL-4 release from basophils.
    Shichijo M, Shimizu Y, Hiramatsu K, Togawa M, Inagaki N, Takagi K, Nagai H.
    Jpn J Pharmacol; 1999 Apr 23; 79(4):501-4. PubMed ID: 10361893
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.